ATLG Levels in Autologous HSCT for Multiple Sclerosis

Clinical trial NCT07635693 · RECRUITING

Trial details

NCT number: NCT07635693
Sponsor: Ciceri Fabio
Status: RECRUITING
Study type: OBSERVATIONAL

Multiple Sclerosis Autologous Hematopoietic Stem Cell Transplant ATLG

Start date: 2026-05-04
Primary completion: 2028-05-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.